The Use of Alpha Lipoic Acid for the Treatment and Prevention of Diabetic Retinopathy

Stopped early · Not applicable

Conditions studied: Moderate Non-proliferative Diabetic Retinopathy

In brief

The purpose of this study is to evaluate the role of alpha lipoic acid in patients who have moderate non-proliferative diabetic retinopathy. The primary aim of this study is to test the hypothesis that the addition of alpha lipoic acid in a diabetic patient's therapeutic regimen can decrease the progression of diabetic retinopathy and preserve visual acuity.

Key facts

Study ID
NCT01880372
Run by
Ferris State University
People needed
1
Starts
2013-09-01
Expected to finish
2016-04-01
Last updated by the study team
2019-02-15

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.